Topic
Thioredoxin-Interacting Protein (TXNIP): A Novel Target for Neuroprotection in Experimental Stroke

Hosted by
Drexel Neurosciences Institute

Speaker
Tauheed Ishrat, PhD, University of Georgia

Learning Objectives
At the conclusion of the activity, participants should be able to:

• Discuss alternative therapeutic strategies for the treatment of stroke
• Examine mechanism by which ischemic stroke–induced TXNIP causes neuronal injury
• Describe role of TXNIP in ischemia/reperfusion injury in hyperglycemic stroke

Target Audience
Faculty, physicians, fellows, residents, medical students, PAs, CRNPs, RNs, all medical specialties

Continuing Medical Education Credits
Drexel University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement
Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AOA
This program is eligible for 1 credit in Category 2A of the American Osteopathic Association.

Disclosure
Speakers at continuing medical education activities are required to disclose to the audience any relevant commercial interest (which is any entity producing, marketing, reselling or distributing health care goods or services consumed by, or used on, patients). Any conflicts of interest must be resolved prior to the presentation and announced to the audience.

All planners, moderators and presenters have nothing to disclose.